International health care products major, Covidien plc (COV) has won the approval of the U.S. Food and Drug Administration (“FDA”) for its motion-tolerant Nellcor pulse oximetry devices. The system ...
International healthcare products major, Covidien plc (COV) has started labeling its Nellcor pulse oximeters to promote the usefulness of the product line for Critical Congenitial Heart Disease (:CCHD ...
BOULDER, Colo.--(BUSINESS WIRE)--Every year, nearly 7,200 infants are born in the United States with a Critical Congenital Heart Disease (CCHD). 1 It is a condition that is often easily detectable and ...
On June 21, Covidien plc ( COV), global innovator and manufacturer of healthcare products, announced the launch of Nellcor SpO 2 single parameter module in North America, European Economic Area (EEA) ...
Medtronic plc MDT recently announced favourable outcome of an independent prospective observational study, which was published online in the Journal of Perinatology. This study compared the efficacy ...
Background and Aims: To be useful in the delivery room, pulse oximeters must provide clinicians with accurate data in the first minutes after birth. This study aimed to identify the sensor application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback